Fresenius Medical Care AG - Depositary Receipt (FMS)
NYSE
Real-time Data
01:30 PM
Day's Range
20.2352 wk Range
20.02Overview - FMS - Fresenius Medical Care AG - Depositary Receipt
Key Statistics
Valuation
Enterprise Value
25.53B
P/E (Trailing)
‪11.83‬
P/E (Forward)
‪7.45‬
PEG Ratio
‪2.27‬
Price / Sales (TTM)
‪0.60‬
Price / Book
‪0.82‬
EV / EBITDA
‪8.35‬
Profitability
Profit Margin
‪4.82%‬
Operating Margin
‪10.77%‬
Return on Assets
‪3.98%‬
Return on Equity
‪8.52%‬
Ownership
Shares Outstanding
532.21M
Float
397.11M
Held by Insiders
‪0.00%‬
Held by Institutions
‪9.86%‬
Price stats
Beta
‪0.82‬
50-Day Avg
‪23.36‬
200-Day Avg
‪23.03‬
Dividends
Payout Ratio
‪45.02%‬
Frequency
Annual
Analyst Consensus
7 analysts
Average price target
‪$ 25.99‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - FMS - Fresenius Medical Care AG - Depositary Receipt
Peers - FMS - Fresenius Medical Care AG - Depositary Receipt
Peer Comparison
Compared with companies in Medical Care Facilities listed on NYSE.
Profile Summary - FMS - Fresenius Medical Care AG - Depositary Receipt
About
Fresenius Medical Care AG - Depositary Receipt is the U.S.-traded American Depositary Receipt for Fresenius Medical Care, a global healthcare company focused on renal care. Fresenius Medical Care provides dialysis products and related services for people with chronic kidney disease, supporting treatment across…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
